Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 159.96B | 154.56B | 153.35B | 131.12B | 116.66B |
Gross Profit | 25.30B | 26.66B | 26.32B | 23.91B | 20.64B |
EBITDA | 12.82B | 12.14B | 12.04B | 10.79B | 8.63B |
Net Income | 6.53B | 6.17B | 6.70B | 5.74B | 3.89B |
Balance Sheet | |||||
Total Assets | 92.74B | 85.53B | 81.30B | 78.66B | 74.82B |
Cash, Cash Equivalents and Short-Term Investments | 13.26B | 10.50B | 7.37B | 13.97B | 15.46B |
Total Debt | 9.18B | 10.56B | 10.30B | 10.90B | 12.46B |
Total Liabilities | 24.77B | 22.43B | 22.68B | 25.05B | 25.99B |
Stockholders Equity | 67.97B | 63.11B | 58.62B | 53.61B | 48.83B |
Cash Flow | |||||
Free Cash Flow | 5.89B | 4.67B | -3.51B | 1.40B | 8.05B |
Operating Cash Flow | 7.33B | 7.72B | -1.21B | 3.62B | 11.03B |
Investing Cash Flow | -849.00M | -2.88B | -1.62B | -3.19B | -3.00B |
Financing Cash Flow | -3.42B | -2.00B | -2.77B | -2.93B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥37.75B | 5.94 | 5.40% | 3.49% | 4.58% | ||
74 Outperform | ¥150.50B | 22.69 | 1.70% | 19.68% | -39.34% | ||
74 Outperform | ¥9.46B | 12.04 | 2.72% | 11.34% | 22.75% | ||
72 Outperform | ¥56.43B | 10.86 | 5.04% | 12.85% | -22.91% | ||
72 Outperform | ¥30.26B | 7.59 | 4.72% | -4.95% | -40.10% | ||
64 Neutral | ¥25.53B | 14.70 | 4.81% | 116.91% | -106.11% | ||
57 Neutral | HK$24.69B | 3.68 | -2.17% | 6.03% | -0.25% | -65.84% |